Nov (NOV) EBITDA (2009 - 2026)

Nov has disclosed EBITDA across 18 years of filings, most recently posting $262.0 million for Q2 2026.

• In Q2 2026, EBITDA rose 27.8% year-over-year to $262.0 million; the TTM figure through Jun 2026 stood at $580.0 million (down 29.53% YoY), while the FY2025 annual figure was $494.0 million, down 43.61% from the prior year.
• EBITDA came in at $262.0 million for Q2 2026 at Nov, up from $119.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $313.0 million in Q2 2024 to a low of -$21.0 million in Q1 2022.
• Average EBITDA over 5 years is $155.2 million, with a median of $162.0 million recorded in 2022.
• Year-over-year, EBITDA soared 1180.0% in 2022 and tumbled 55.56% in 2025.
• Over 5 years, EBITDA stood at $162.0 million in 2022, then declined by 0.62% to $161.0 million in 2023, then increased by 28.57% to $207.0 million in 2024, then plunged by 55.56% to $92.0 million in 2025, then jumped by 184.78% to $262.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $262.0 million in Q2 2026, $119.0 million in Q1 2026, and $92.0 million in Q4 2025.